AuditLine › HHS OIG › Food and Drug Administration
HHS OIG recommendation 22-A-01-069.03
We recommend that the Food and Drug Administration conduct an analysis of the workloads of individuals responsible for: (1) determining final…
The publisher's file lists October 3, 2026 as the date the next update was expected. That date has passed. This is the publisher's own date field, not a finding that anyone missed a deadline.
The recommendation, in the publisher's words
We recommend that the Food and Drug Administration conduct an analysis of the workloads of individuals responsible for: (1) determining final classification, (2) issuing warning letters, and (3) holding regulatory meetings, and address any potential issues identified by this analysis.
- Responsible agency
- Food and Drug Administration
- Issued
- June 24, 2022
- Report
- The Food and Drug Administration's Foreign For-Cause Drug Inspection Program Can Be Improved To Protect the Nation's Drug Supply (A-01-19-01500) · find it at HHS OIG
- Kind of report
- Audit
- Agency response
- Concur (as recorded by the publisher)
- Last update received
- March 18, 2026
- Next update expected
- October 3, 2026 (publisher's date)
- Publisher topics
- Food; Drug and Device Safety
“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.
Dated history
- Issued by HHS OIG. (publisher's date)
- First recorded by AuditLine. (start of AuditLine's own history for this record)
Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.
Other recommendations from this report
5 more, of which 0 are open in the publisher's file.
- We recommend that the Food and Drug Administration identify and implement additional ways to improve the timeliness of its foreign for-cause drug inspection process.HHS OIG 22-A-01-069.01 · issued Jun 24, 2022 · closed Apr 3, 2026Closed Implemented
- We recommend that the Food and Drug Administration consider streamlining the process for writing and reviewing EIRs to minimize potential delays due to unexpected events.HHS OIG 22-A-01-069.02 · issued Jun 24, 2022 · closed Mar 12, 2024Closed Implemented
- We recommend that the Food and Drug Administration implement policies and procedures to ensure that lead investigators assigned to inspections have completed the Level 1 Investigator…HHS OIG 22-A-01-069.04 · issued Jun 24, 2022 · closed Nov 13, 2025Closed Implemented
- We recommend that the Food and Drug Administration ensure that supervisors review investigators' qualifications and document that they meet applicable training requirements when the…HHS OIG 22-A-01-069.05 · issued Jun 24, 2022 · closed May 20, 2024Closed Implemented
- We recommend that the Food and Drug Administration review the training records of the lead investigators that were outside the scope of the audit to verify that documentation supports…HHS OIG 22-A-01-069.06 · issued Jun 24, 2022 · closed May 20, 2024Closed Implemented
Source
Open this report in HHS OIG's tracker This publisher's records (CSV)
Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows,
SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.